Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates

Ardelyx (ARDX) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of$ 0.10. This compares to loss of $0.08 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 30%. A quarter ago, it was expected that this biotechnology company would post a loss of$ 0.13 per share when it actually produced a loss of $0.11, delivering a surprise of 15.38%.Over the last four quarters, the company has surpa ...